✦ LIBER ✦

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma

✍ Scribed by Cary A. Presant; Albert Van Amburg III; Carol Klahr

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 584 KB
Volume: 40
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197709)40:3<987::aid-cncr2820400304>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin, 1,3-bis (2-chloroethyl)-1-ni

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962), cyclophosphamide plus prednisone (ABC-P) in melphalan-resistant multiple myeloma

✍ Cary A. Presant; Carol Klahr 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 1 views

Adriamycin, 1,3-bis (2-chloroethyl)-1-ni

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors

✍ Cary A. Presant; J. Fred Kolhouse; Carol Klahr 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

Phase II study of 1,3-Bis (2-chloroethyl

Phase II study of 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC #409962) with amphotericin B in bronchogenic carcinoma

✍ Cary A. Presant; Stephen Hillinger; Carol Klahr 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

Eighteen patients with unresectable bronchogenic carcinoma were treated with amphotericin B (7.5 mgim' on day I , I5 mg/m2 on day 2, and 30 mg/m2 on days 3 and 4) plus BCNU (250 mg/m2 on day 4 following amphotericin B) with courses of therapy repeated every 8 weeks. All patients had metastatic disea

Phase I evaluation of the combination 1,

Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases

✍ Creagan, Edward T. ;Eagan, Robert T. ;Rubin, Joseph 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB